VYGR vs. PSILX

Last updated Jun 16, 2026

VYGR (Voyager Therapeutics, Inc.) is a stock, while PSILX (T. Rowe Price Spectrum International Equity Fund) is Foreign Large Cap Equities fund managed by T. Rowe Price. Over the past 10 years, VYGR returned -12.79%/yr vs 8.88%/yr for PSILX. At a 0.30 correlation, their price movements are largely independent.

Performance

VYGR vs. PSILX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Voyager Therapeutics, Inc. (VYGR) and T. Rowe Price Spectrum International Equity Fund (PSILX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, VYGR achieves a -7.63% return, which is significantly lower than PSILX's 12.26% return. Over the past 10 years, VYGR has underperformed PSILX with an annualized return of -12.79%, while PSILX has yielded a comparatively higher 8.88% annualized return.

VYGR

• 1D: 3.71%
• 1M: -3.59%
• YTD: -7.63%
• 6M: -16.74%
• 1Y: 10.00%
• 3Y*: -34.59%
• 5Y*: -5.51%
• 10Y*: -12.79%

PSILX

• 1D: 0.46%
• 1M: 3.76%
• YTD: 12.26%
• 6M: 14.02%
• 1Y: 27.05%
• 3Y*: 16.34%
• 5Y*: 6.27%
• 10Y*: 8.88%

*Multi-year figures are annualized to reflect compound growth (CAGR)

VYGR vs. PSILX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
VYGR Voyager Therapeutics, Inc.	-7.63%	-30.69%	-32.82%	38.36%	125.09%	-62.10%	-48.75%	48.40%	-43.37%	30.30%
PSILX T. Rowe Price Spectrum International Equity Fund	12.26%	30.30%	4.28%	13.83%	-18.04%	5.00%	13.94%	25.00%	-14.83%	26.79%

Correlation

The correlation between VYGR and PSILX is 0.35, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.35
Correlation (3Y) Calculated over the trailing 3-year period	0.36
Correlation (5Y) Calculated over the trailing 5-year period	0.31
Correlation (10Y) Calculated over the trailing 10-year period	0.31
Correlation (All Time) Calculated using the full available price history since Nov 11, 2015	0.30

Return for Risk

VYGR vs. PSILX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VYGR

VYGR Risk / Return Rank: 48
VYGR Sharpe Ratio Rank: 47
VYGR Sortino Ratio Rank: 48
VYGR Omega Ratio Rank: 46
VYGR Calmar Ratio Rank: 48
VYGR Martin Ratio Rank: 48

PSILX

PSILX Risk / Return Rank: 40
PSILX Sharpe Ratio Rank: 40
PSILX Sortino Ratio Rank: 39
PSILX Omega Ratio Rank: 43
PSILX Calmar Ratio Rank: 37
PSILX Martin Ratio Rank: 40

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

VYGR vs. PSILX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Voyager Therapeutics, Inc. (VYGR) and T. Rowe Price Spectrum International Equity Fund (PSILX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	VYGR	PSILX	Difference
Sharpe ratio: Return per unit of total volatility	0.15	1.59	-1.43
Sortino ratio: Return per unit of downside risk	0.72	2.25	-1.53
Omega ratio: Gain probability vs. loss probability	1.08	1.30	-0.22
Calmar ratio: Return relative to maximum drawdown	0.27	2.04	-1.77
Martin ratio: Return relative to average drawdown	0.48	7.72	-7.24

VYGR vs. PSILX - Sharpe Ratio Comparison

The current VYGR Sharpe Ratio is 0.15, which is lower than the PSILX Sharpe Ratio of 1.59. The chart below compares the historical Sharpe Ratios of VYGR and PSILX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

VYGR vs. PSILX - Drawdown Comparison

The maximum VYGR drawdown since its inception was -92.11%, which is greater than PSILX's maximum drawdown of -61.38%. Use the drawdown chart below to compare losses from any high point for VYGR and PSILX.

Drawdown Indicators

	VYGR	PSILX	Difference
Max Drawdown Largest peak-to-trough decline	-92.11%	-61.38%	-30.73%
Max Drawdown (1Y) Largest decline over 1 year	-37.71%	-12.72%	-24.99%
Max Drawdown (3Y) Largest decline over 3 years	-80.49%	-13.70%	-66.79%
Max Drawdown (5Y) Largest decline over 5 years	-80.49%	-33.13%	-47.36%
Max Drawdown (10Y) Largest decline over 10 years	-92.11%	-33.33%	-58.78%
Current Drawdown Current decline from peak	-88.41%	-1.66%	-86.75%
Average Drawdown Average peak-to-trough decline	-66.91%	-14.05%	-52.86%
Ulcer Index Depth and duration of drawdowns from previous peaks	21.10%	3.32%	+17.78%

Volatility

VYGR vs. PSILX - Volatility Comparison

Voyager Therapeutics, Inc. (VYGR) has a higher volatility of 19.66% compared to T. Rowe Price Spectrum International Equity Fund (PSILX) at 6.70%. This indicates that VYGR's price experiences larger fluctuations and is considered to be riskier than PSILX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	VYGR	PSILX	Difference
Volatility (1M) Calculated over the trailing 1-month period	19.66%	6.70%	+12.96%
Volatility (6M) Calculated over the trailing 6-month period	43.72%	14.03%	+29.69%
Volatility (1Y) Calculated over the trailing 1-year period	65.19%	16.33%	+48.86%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	80.85%	15.94%	+64.91%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	75.87%	16.28%	+59.59%

Dividends

VYGR vs. PSILX - Dividend Comparison

VYGR has not paid dividends to shareholders, while PSILX's dividend yield for the trailing twelve months is around 4.83%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
PSILX T. Rowe Price Spectrum International Equity Fund	4.83%	5.42%	2.04%	1.88%	6.67%	3.49%	0.88%	3.49%	6.69%	0.58%	0.17%	0.08%
VYGR Voyager Therapeutics, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both VYGR and PSILX in my portfolio?

VYGR and PSILX have a correlation of 0.35, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, VYGR or PSILX?

VYGR has higher volatility (19.66%) compared to PSILX (6.70%). In terms of maximum drawdown, VYGR dropped -92.11% vs PSILX's -61.38%.

Which has better risk-adjusted returns?

PSILX currently has the higher Sharpe Ratio (1.59 vs 0.15), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.